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Highlights 
- Peroxynitrite is a potent nitrating and oxidizing agent 
- Peroxynitrite is generated during pathological situations affecting the heart 
- The caspase-generated RasGAP fragment N has anti-apoptotic properties 
- Peroxynitrite induces fast cleavage of fragment N and no associated cell protection 
- A cleavage-resistant form of fragment N inhibits peroxynitrite-induced death 
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Abstract 
 
Peroxynitrite (PN) it is a potent nitrating and oxidizing agent generated during 
various pathological situations affecting the heart. PN negative effects result, 
at least in part, by its ability to activate caspases and apoptosis. RasGAP is a 
ubiquitously expressed protein that is cleaved sequentially by caspase-3. At 
low caspase-3 activity, RasGAP is cleaved into an N-terminal fragment, 
called fragment N, that protects cells by activating the Ras/PI3K/Akt pathway. 
At high caspase-3 activity, fragment N is further cleaved and this abrogates 
its capacity to stimulate the anti-apoptotic Akt kinase. Fragment N formation 
is crucial for the survival of cells exposed to a variety of stresses. Here we 
investigated the pattern of RasGAP cleavage upon PN stimulation and the 
capacity of fragment N to protect cardiomyocytes. PN did not lead to 
sequential cleavage of RasGAP. Indeed, PN did not allow accumulation of 
fragment N because it induced its rapid cleavage into smaller fragments. No 
situations were found in cells treated with PN where the presence of 
fragment N was associated with survival. However, expression of a caspase-
resistant form of fragment N in cardiomyocytes protected them from PN-
induced apoptosis. Our results indicate that the anti-apoptotic pathway 
activated by fragment N is effective in inhibiting PN-induced apoptosis (as 
seen when cardiomyocytes express a capase-3-resistant form of fragment N) 
but because fragment N is too transiently generated in response to PN, no 
survival response is effectively produced. This may explain the marked 
deleterious consequences of PN generation in various organs, including 
heart. 
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Introduction 
Peroxynitrite (PN), the product of superoxide-mediated nitric oxide oxidation, 
has toxic and damaging effects in cells [1]. PN-induced cellular damage is 
mediated by protein nitration and oxidation of tyrosine residues, anti-oxidant 
depletion (e.g. inactivation of glutathione peroxidase), and modifications of 
DNA bases [2]. This impacts on the modulation of several signal transduction 
pathways including the phosphoinositide 3-kinase/Akt pathway and mitogen 
activated protein kinase pathways [3, 4]. PN can also lead to executioner 
caspase activation and apoptosis [5-8]. PN generation plays an important 
role in oxidative and nitrosative stress in various patho-physiological 
situations, including myocardial injury, heart failure and cardiomyopathy [9]. 
RasGAP is an ubiquitously expressed, multi-domain protein that acts as a 
regulator of Ras and Rho GTP-binding proteins. RasGAP contains two 
conserved caspase-3 cleavage sites [10]. At low caspase-3 activity levels, 
RasGAP is cleaved at position 455. The resulting N-terminal fragment 
(fragment N) activates a potent anti-apoptotic-signaling pathway mediated by 
the Ras/PI3K/Akt pathway [11], which is crucial for cell survival in low stress 
conditions [12]. However, at higher caspase 3 activity, fragment N is further 
cleaved at position 157, abrogating its anti-apoptotic activity [13]. The 
fragments resulting from this second cleavage (in particular fragment N2 
[RasGAP 158-455)]) regulate tumor cell death by sensitizing them to anti-
cancer treatment-induced apoptosis [13]. Therefore RasGAP acts as a 
sensor of caspase activity that controls the balance between cell death and 
survival. Over-expression of an uncleavable form of fragment N in vitro 
protects various cell types against genotoxins, death receptor ligands, UV-c, 
staurosporine, and inflammatory cytokines [12, 14]. Moreover, transgenic 
mice expressing fragment N specifically in pancreatic beta cells are more 
resistant against pro-diabetogenic conditions and their beta cells experience 
less apoptosis in such situations [15, 16]. 
The capacity of fragment N to protect cells against protein nitration- and 
oxidation-induced death has not been investigated yet. Here, we have 
evaluated how PN modulates the formation of fragment N and how efficient 
fragment N was in counteracting PN-induced cell death. 
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Materials and Methods 
 
Cells 
H9C2 cells, a rat heart clonal cell line (ATCC, Manassas, VA) [17], and HEK 
293 cells (ATCC, Manassas, VA catalog n°CRL-1573) were grown in 
Dulbecco’s modified Eagle’s medium (DMEM; GIBCO, catalog n°61965) 
supplemented with 10% fetal calf serum (Invitrogen, catalog n° 41Q2174K), 
100 units/ml penicillin, and 0.1 mg/ml streptomycin (Sigma, catalog n° 
P0781). HeLa cells were maintained in RPMI 1640 (GIBCO catalog n° 
61870-10) containing 10% fetal calf serum. All these cells were cultured at 
37°C and 5% CO2. 
 
Primary culture of neonatal mouse cardiomyocytes 
Hearts were isolated from 1-2 days old new born mice killed by decapitation 
and placed on ice in ADS buffer [1.1 M NaCl, 1 M Hepes, 0.48 M KCl, 0.1M 
NaH2PO4 , 0.12 M MgSO47H2O, 0.55 M Glucose). Ventricles without atria 
were digested in ADS containing 0.45 mg/ml collagenase (Worthington 
Biochemical Corp.) and 1 mg/ml pancreatin (Invitrogen Corp.) as described 
[18]. Briefly, the tissue homogenates were incubated for 15 minutes at 37 ºC 
rocking at 700 rpm. The supernatants were collected and the pellets were 
subjected to two additional rounds of digestion in 1.5 ml ADS containing 
collagenase and pancreatin. The supernatants collected out from the three 
digestion rounds were mixed and plated in 10 cm-culture dishes (10 
ventricles per dish) for two rounds of 45 minute-differential plating at 37 ºC 
and 10% CO2. Cells in the supernatants of the first differential plating were 
collected and replated for second differential plating. The cells in the 
supernatants of the second plating were collected, washed once in 5 ml of a 
3:1 mixture of DMEM and Medium 199 (Invitrogen) supplemented with 10% 
horse serum (Oxoid), 5% Fetal Calf Serum (Invitrogen), 100 U/ml penicillin, 
and 0.1 μg/ml streptomycin centrifuged for 10 minutes at 192 g at room 
temperature. Seventy-five thousand cells were seeded onto 0.1% gelatin-
coated 24 well-plates. 
 
Chemicals and Antibodies 
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Peroxynitrite was supplied as a 50 mM stock in 0.3 M sodium hydroxide, 
(Cayman Chemicals; catalog n°81565). Hoechst 33342 was from Roche 
(catalog n°H-1399). It was diluted in water at a final concentration of 10 
mg/ml and stored at 4°C in the dark. The anti-RasGAP antibody was from 
Enzo Life Science (catalog number ALX-210-860-R100) and is directed at 
the fragment N2 moiety of the human protein (amino acids 158-455). The 
anti-phospho serine 473-Akt rabbit polyclonal IgG antibody as well as anti 
caspase-3 monoclonal antibodies were from Cell Signaling Technology 
(catalog n°9271 and 9665 respectively). The mouse polyclonal IgG antibody 
recognizing sarcomeric alpha-actinin was from Sigma (catalog n°A78811). 
The monoclonal antibody specific for the HA tag was purchased as ascites 
from Babco (Richmond,CA; catalog n°MMS-101R). This antibody was 
adsorbed on HeLa cell lysates to decrease non-specific binding as previously 
described [10]. Secondary antibodies for Western blot were donkey anti-
mouse fluorescein-conjugated antibody and donkey anti-rabbit Cy3-
conjugated antibody (Jackson ImmunoResearch, catalog n°715-095-1507 
and catalog n°711-165-152, respectively). The secondary antibody used in 
the immunocytochemistry was Cy3-conjugated AffiniPure Goat anti-Mouse 
IgG (H+L) from Jackson Immuno Research Laboratories (catalog n°115-165-
146). Alexa Fluor 680 goat anti-rabbit IgG (H+L) (Molecular Probes; catalog 
n°A21109) and IRDye 800-conjugated affinity purified anti-Mouse IgG (H+L) 
(Rockland catalog n°610-132-121) were the secondary antibodies used on 
Western blots. HRP-goat anti-mouse and HRP-goat anti-rabbit antibodies 
were from Jackson Immuno Research (catalog n°211-035-146 and 211-035-
109, respectively). The chemiluminescent HRP substrate was from Witec AG 
(catalog n°K-12043-D20) 
 
Plasmids 
HA-hRasGAP[1-455](D157A).lti (#353) (previously called N-D157A.lti) is a 
lentiviral vector encoding the uncleavable form of fragment N [14]. HA-
hRasGAP[1-455].lti (#769) is a lentiviral vector encoding the HA-tagged 
wild-type form of fragment N. It was constructed by sub-cloning the 1423 bp 
fragment isolated from the BamHI/XhoI digestion of HA-hRasGAP[1-455].dn3 
(#14) (previously named HA-GAPN.dn3 and described in [10]) into the TRIP-
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PGK-ATGm-MCS-WHV (#349) lentiviral vector opened with the same 
restriction enzymes. Myr-mAkt1-HA.cmv (#249), which encodes a 
constitutively active form of Akt that bears a Src myristoylation sequence at 
its N-terminus and an HA tag at its C-terminus, was described earlier under 
the name myr-Akt.cmv [11]. Plasmid hIkB alpha delta N2.cmv (#11) 
encodes the human IkBa protein with the DN2 deletion (i.e. amino acid 3–
71); this constructs cannot be phosphorylated by IkB kinases and degraded 
by the proteasome and therefore functions as an inhibitor of NF-B. It has 
been described before under the name of IkBαΔN2 [11]. The pEGFP-C1 (#6) 
plasmid encoding the green fluorescent protein (GFP) is from Clonetech. 
Stag.dn3 (#763) was generated by sub-cloning the following two 
oligonucleotides into pcDNA3 (#1; Invitrogen) opened with HindIII and XbaI: 
oligo # 806 [AGCTT (N2-N6 of HindIII site), CCCGGG (SmaI), CCACC 
(Kozak; N6 of SmaI provides the first nucleotide of the Kozak sequence), 
ATG (start codon), AAA GAA ACC GCT GCT GCT AAA TTC GAA CGC 
CAG CAC ATG GAC AGC (S·tag), TAA (stop codon), T (N1 of XbaI site)] 
and oligo # 807 [CTAGA (N5-N1 of XbaI site), TTA (stop codon), GCT GTC 
CAT GTG CTG GCG TTC GAA TTT AGC AGC AGC GGT TTC TTT (S Tag), 
CAT (start codon) GGTGG (Kozak sequence), CCCGGG (SmaI), A (N6 of 
HindIII site)]. Stag-hRasGAP[158–455].dn3 (#754) encodes the S-tagged 
form of fragment N2 (S·tag-N2) [19] 
 
 
Lipofectamine transfection 
H9C2 cells were co-transfected with a GFP-encoding plasmid in combination 
with the indicated plasmids using lipofectamine 2000 (Life Technologies; 
catalog n°11668-019). After transfection, the cells were incubated in serum-
containing medium for 48 hours at 37°C, 5% CO2. At that time, the 
percentage of GFP-positive H9C2 cells is about 30%. 
 
Apoptosis scoring based on nuclear morphology 
Apoptosis was determined by scoring the number of cells displaying pycnotic 
nuclei as described previously [20]. 
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Apoptosis scoring based on quantitation of cytoplasmic histone-
associated-DNA fragments 
Apoptosis was monitored by quantifying the cytoplasmic histone-associated-
DNA fragments using cell death detection ELISA plus from Roche (catalog 
n°1-774-425-001). After the indicated treatments described in Fig. 5, cells in 
24 well-plates were washed once with ice-cold PBS and then lysed in 200 µl 
of the kit lysis buffer for 30 minutes on ice. The lysates were centrifuged at 
200 g for 10 minutes. Supernatants contain the cytoplasmic fraction while 
pellets contain the nuclei and high molecular weight non-fragmented DNA. 
Twenty µl of the supernatants were transferred to streptavidin-coated 96-well 
microplate to which 80 µl of an immuno-reagent mixture containing two 
antibodies, a biotin-labeled anti-histone antibody which binds to H1, H2A, 
H2B, H3 and H4 histones and that will therefore retain histone proteins in the 
wells through biotin-streptavidin binding, and a HRP-labeled anti-DNA-POD 
antibody which reacts with single or double stranded histone-associated 
DNA. The plates were then incubated for 2 hours at room temperature with 
gentle shaking (300 rpm). After this incubation period the wells were washed 
3 times with 250 µl of the incubation buffer, 100 µl of HRP substrate were 
added, and the plate was incubated at room temperature for an additional 15-
20 minute period with gentle shaking. The reaction was stopped by adding 
100 µl of stop solution. Absorbance was measured at 405 nm in triplicates. In 
each experiment a background control (incubation buffer only mixed with the 
ABTS stop solution) and a negative control (untreated cells) were performed. 
The background value was subtracted to all measurements. An enrichment 
factor, corresponding to the level of mono- and oligo-nucleosomes released 
to the cytoplasm, was calculated by dividing the corrected absorbance from 
the experimental conditions with the corrected negative control value. 
 
Stimulation with PN 
PN was delivered to the cells as a single bolus at a 1:100 dilution against one 
side of the dish, while rapidly swirling the medium to ensure optimal exposure 
of the cells to PN, which was used at final concentrations ranging from 12.5 
to 500 μM, which are in agreement with the concentrations of PN used in 
previous in vitro studies investigating the mechanisms of PN cytotoxicity [4, 
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17, 21]. Although such concentrations may appear elevated at first glance, it 
is noteworthy that, due to the rapid decomposition of PN, the cells are 
actually exposed to lower concentration of this agent. Indeed, it has been 
determined that bolus addition of 50-500 µM PN to cultured cells resulted in 
an actual exposure of 5-50 µM of the oxidant. Furthermore, the 
concentrations of PN used in our study are physiologically relevant, as it has 
been estimated that the rate of PN generation may reach up to 1 mM min-1 in 
an inflamed organ such as the lung in vivo. 
 
Lentiviral infection 
Recombinant lentiviruses were produced as described previously [14]. 
 
Western blot 
Cells were lysed in monoQ-C buffer (70 mM β-glycerophosphate, 0.5% Triton 
X-100, 2 mM MgCl2, 100 mM Na3VO4, 1 mM dithiothreitol, 20 μg/ml 
aprotinin) and protein quantification was performed by the Bradford 
technique. Equal amounts of proteins were subjected to SDS PAGE and then 
transferred onto a nitrocellulose membrane (Biorad catalog nº162 0115). The 
membranes were blocked with TBS-Tween 20 0.1% containing 5% non-fat 
milk and incubated over night at 4°C with the specific primary antibodies. 
Blots were then washed with TBS-Tween 0.1%, incubated with the 
appropriate secondary antibody (1:5000 dilution) 1 hour at room temperature 
and subsequently visualized and quantified with the Odyssey infrared 
imaging system (LICOR Biosciences, Bad Homburg, Germany) or with the 
Chemidoc XRS+ system (Biorad laboratories). In some instances, the blots 
were stripped and reprobed. This was performed by incubating the blots at 
50°C for 30 minutes in stripping buffer (62.5 mM Tris-base, 100 mM -
mercaptoethanol, 1% SDS, pH to 6.7) followed by three 20 minute-long 
washes at room temperature in TBS-tween 0.1%. 
 
Immuno-cytochemistry 
Cells were grown on glass coverslips, two days post-infection, the cells were 
fixed and immuno-cytochemistry was performed as previously described [22]. 
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Statistical analysis 
Results are shown as mean ± 95% confidence intervals. The statistical 
analyses used in this study were one-way ANOVAs and paired Student’s 
test. In the latter case, the difference between the indicated conditions was 
considered significant when p < 0.05/n, where p is the probability derived 
from the t test analysis and n is the number of comparisons done (Bonferroni 
correction). Statistically significant differences are indicated by asterisks. 
 
Ethics Statement 
Experiments on the mice were carried out in strict accordance with the Swiss 
Animal Protection Ordinance (OPAn) and in conformation with directive 
2010/63/EU of the European Parliament. The protocol was approved by the 
Veterinary office of the state of Vaud, Switzerland (approval reference 
number 2185). 
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Results 
 
Pattern of PN-induced RasGAP cleavage in H9C2 cells 
In order to investigate the pattern of RasGAP cleavage upon PN stimulation, 
we exposed H9C2 embryonic rat heart myoblast cells [23] to a dose of 250 
µM of PN for different periods of time (Fig. 1). Consistent with previous 
studies [8], starting 2 hours post stimulation, PN induced increased levels of 
caspase-3 activation and apoptotic cell death (Fig. 1A and C). This was 
accompanied by cleavage of RasGAP into fragments N and N2 (Fig. 1B). In 
subsequent experiments, the 4 hour post PN stimulation time point was 
chosen as it allowed PN to efficiently induce its cellular responses. 
Exposure of H9C2 cells to increasing doses of PN induced cleavage of 
caspase-3 activation (Fig. 2A) and RasGAP into fragment N (Fig. 2B). This 
correlated with Akt activity induction (Fig. 2D). However, there were no 
conditions where fragment N was produced without a concomitant generation 
of fragment N2 (Fig. 2B). Moreover, fragment N production did not correlate 
with cell survival (Fig. 2C) and caspase-3 activation (Fig 2A). These results 
indicate that PN is not able to induce sequential cleavage of RasGAP and 
accumulation of fragment N in H9C2 cells that would result in a cell 
protection response. 
 
Cisplatin induces sequential cleavage of RasGAP in H9C2 cells 
The absence of sequential cleavage of RasGAP in PN-treated H9C2 cells 
could be due to a peculiarity of this cell line. To assess this point, H9C2 cells 
were treated with increasing doses of cisplatin, which is known to induce 
sequential cleavage of RasGAP in other cell types [12]. Fig. 3B shows that 
low concentrations of this genotoxin (< 10 M) led to fragment N generation 
in H9C2 cells before fragment N2 was substantially produced and that this 
correlated with cell survival (Fig. 3C) and mild caspase-3 activation (Fig. 3A). 
Akt stimulation in these conditions was not increased (Fig. 3D). At higher 
concentrations of cisplatin (>10 M), fragment N2 levels markedly increased 
(Fig. 3B), caspase-3 was strongly activated (Fig. 3A), levels of active Akt 
decreased (Fig. 3D), and apoptosis occurred (Fig. 3C). These results 
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demonstrate that partial cleavage of RasGAP into the anti-apoptotic RasGAP 
fragment N can occur in H9C2 cells as seen in other cells types [12].  
 
PN induces RasGAP cleavage in a non-sequential manner 
To assess whether the inability of PN to induce a sequential cleavage of 
RasGAP could be observed in other cell types than H9C2 cells, HeLa cells 
were treated with increasing concentrations of this compound. PN induced a 
similar pattern of caspase-3 activation, RasGAP cleavage, increased Akt 
activation, and apoptosis in HeLa cells as compared to H9C2 cells (Fig. 4). 
These results indicate that when PN induces the cleavage of RasGAP and 
fragment N generation, fragment N is rapidly processed further into smaller 
fragments. Hence, there are no concentrations of PN that preferentially 
generate fragment N and that correlate with cell survival, low caspase-3 
activity and Akt activation. 
 
Ectopic expression of a caspase-resistant form of fragment N protects 
cardiomyocytes from PN-induced apoptosis 
One possiblity to explain the lack of protection mediated by the endogenously 
generated fragment N in response to PN is its rapid cleavage. Therefore, if 
fragment N were not to be degraded, it could counteract PN-induced death. 
In order to test this possiblity, wild-type fragment N and the uncleavable 
D157A form were ectopically expressed in H9C2 cells (Fig. 5A) before 
challenging them with low and high PN concentrations. As hypothesized, 
wild-type fragment N was degraded in response to PN stimulation while the 
cleavage resistant mutant was not (Fig. 5B and C). Over-expression of both 
fragment N forms inhibited caspase-3 activation and apoptosis induced by 
low PN concentration (50 µM) (Fig. 5B and D), although for apoptosis this did 
not reach statistical significance in the case of wild-type fragment N (Fig. 5D). 
At high PN concentration (250 M), only the D157A fragment N mutant 
inhibited caspase-3 activation and apoptosis (Fig. 5 B and D), indicating that 
fragment N, if not degraded, efficiently protects cells against PN-induced 
death. 
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Fragment N has been shown to activate the prosurvival Akt kinase [11]. To 
investigate the prosurvival signals induced by fragment N in cardiomyocytes 
stimulated or not with PN, we monitored the levels of Akt-Ser473 
phosphorylation in conditions where the wild-type and uncleavable D157A 
forms of fragment N were overexpressed. As expected in control H9C2 cells 
(i.e. cells not stimulated with PN), both forms of fragment N stimulated Akt 
phosphorylation (Fig. 5B; compare the 0 M lanes). PN was found, as 
reported earlier [4, 24], to promote Akt-Ser473 phosphorylation (Fig. 5B; first 
three lanes). However, in the presence of 50 M of PN, Akt activation was 
more pronounced in H9C2 cells over-expressing fragment N (Fig. 5B; 
compare the 50 M lanes). In the presence of 250 M of PN, Akt was 
strongly stimulated and no further increase was brought upon over-
expression of fragment N (Fig. 5B; compare the 250 M lanes). 
To clarify the potential role of Akt in protecting cardiomyocytes against PN, 
H9C2 cells were transfected with a myristoylated constitutively active form of 
Akt (myr-Akt) and their sensitivity to PN-induced apoptosis was monitored. 
The myr-Akt protein was, as expected from its constitutive activity, 
phoshorylated on Ser473 (Fig. 5E) and was able to inhibit apoptosis induced 
by low PN concentrations (50 µM). However at high PN concentrations (250 
M), myr-Akt no longer protected cells (Fig. 5E). These results suggest that 
Akt activation can mediate the protection induced by fragment N in 
cardiomyocytes subjected to low concentrations of PN but that there are 
other pro-survival signals activated by fragment N that allow cardiomyocyte 
survival at high PN concentrations. 
One possibility that could explain the differential capacity of wild-type 
fragment N and the D157 form of the fragment to protect cardiomyocyte is 
that the former can be cleaved into smaller fragments (e.g. fragment N2) that 
have been shown to sensitize tumor cells to apoptosis induced by various 
stimuli [13, 25, 26]. We therefore determined whether fragment N2 can 
sensitize H9C2 cells, which despite having been immortalized are however 
not tumor cells [23], to PN-induced apoptosis. Figure 5F shows that ectopic 
expression of fragment N2 in H9C2 cells did not modulate their sensitivity to 
PN-induced death. This indicates that the lower capacity of fragment N to 
protect cardiomyocyte from PN-induced apoptosis compared to the 
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uncleavable fragment N mutant likely results from its degradation rather than 
the generation of pro-apoptotic fragments such as N2. 
Finally, we investigated whether fragment N was able to protect primary 
cardiomyocytes, the purity of which was assessed by -actinin staining (Fig. 
6A). Ectopic expression of wild-type fragment N and the D157A caspase-
resistant form of the fragment both led to Akt activation in primary 
cardiomyoctes (Fig. 6B; compare the 0 M lanes). Wild-type fragment N 
inhibited caspase-3 activation in primary cardiomyocytes stimulated with low, 
but not high, concentrations of PN. In contrast, the D157A fragment N mutant 
was able to efficiently reduce caspase-3 activation even at high PN 
concentrations. This ability of the D157A form of fragment N to inhibit 
caspase-3 activation was associated with a marked reduction in PN-induced 
primary cardiomyocyte apoptosis (Fig. 6C-D). Thus, the pathways activated 
by fragment N are able to efficiently protect cardiac cells from PN-induced 
cell death. 
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Discussion 
Earlier work has shown that RasGAP is cleaved by caspase-3 sequentially in 
response to increasing concentrations or doses of stress-inducing agents. 
This was seen in different cell types exposed to cisplatin, UV light, Fas ligand 
and doxorubicin [12, 13]. In contrast we provide evidence here that PN does 
not promote sequential cleavage of RasGAP regardless of whether the cells 
used are of cardiomyocyte origin or not. No concentration of PN was found 
that would lead to the partial cleavage of RasGAP into fragment N and that 
would be associated with cell survival. Fragment N was generated in cells 
treated with PN but was apparently immediately degraded further into smaller 
fragments (N1 and N2) that cannot activate the Akt protective pathway [13]. 
When the wild-type form of fragment N was ectopically expressed in cells, it 
failed to inhibit PN-induced apoptosis and this was associated with its 
degradation. In contrast, a caspase-resistant form of fragment N efficiently 
protected immortalized (Fig. 5) and primary cardiomyocytes (Fig. 6) against 
PN-induced death. The anti-apoptotic signals generated by fragment N are 
therefore able to counteract apoptosis induced by PN in cells. 
PN has a short half life, ~1.9 sec at pH 7.4 [27], yet it induces potent and 
adverse effects on cellular processes by modulating signal transduction 
pathways involving Akt, MAPKs (ERK, c-jun, p38), protein kinase C, and NF-
кB (reviewed in [3]). Moreover, PN has the potential to activate multiple 
caspases including caspase-2, -3, -6, -7, 8 and -9 and thus the cleavage of 
key cellular proteins such as poly(ADP-ribose) polymerase and lamins [5]. 
Considering these broad effects on multiple cellular targets, it appears that 
upon PN stimulation, caspase activation is an all-or-nothing phenomenon. 
Indeed, PN induces a monophasic caspase-3 activation where fragment N 
and fragment N2 are concomittantly produced and apoptosis occurs (Fig. 2 
and 4). This contrasts with the situation observed with cisplatin that induces a 
biphasic caspase-3 activation, the first phase (low activation) associated with 
fragment N production, no formation of fragment N2, and cell survival; the 
second phase (high activation) associated with fragment N degradation into 
fragment N2 and apoptosis (Fig. 3). 
Interestingly, Akt, the PI3K effector kinase that has been demonstrated to 
mediate fragment N-induced anti-apoptotic responses [11, 12, 14-16], is 
strongly activated by PN. The ability of PN to modulate Akt is poorly 
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understood. In some cell types (pheochromocytoma cells, endothelial cells, 
macrophages), PN was shown to efficiently inhibit Akt, while in others PN 
exposure resulted in strong stimulation of the kinase (skin fibroblasts, 
hepatoma cell lines, neural cells) [3, 28]. It is suggested that it is the nitration 
capacity of PN that induces Akt inhibition while it is its oxidative properties 
that mediate Akt activation [3, 28]. Our results indicate that cardiomyocytes 
and HeLa cells fall in the second category as PN activates Akt in these cells. 
Nevertheless, activation of Akt by PN in cardiac cells does not impede 
apoptosis and may therefore represent a futile protection attempt. Yet, 
expression of a constitutively active form of Akt in cardiomyocytes inhibits 
apoptosis induced by low concentrations of PN (Fig. 5E). This could therefore 
be one mechanism used by fragment N to protect cardiomyocyte when the 
surrounding concentrations of PN are not too elevated. However, fragment N 
apparently uses additional means to inhibit apoptosis of cardiomyocytes 
exposed to high concentrations of PN because the active form of Akt does 
not inhibit apoptosis in these conditions (Fig. 5E). Hence, signaling pathway 
others than, or in parallel to, Akt activation could participate in the protection 
mediated by caspase-resistant forms of fragment N in cardiac cells. The NF-
кB transcription factor is a downstream target of Akt [29, 30]. However, in the 
presence of fragment N, Akt-mediated NF-кB activation is inhibited [11, 14, 
16]. NF-B activation leads to cell death of beta cells [31] and the KB 
epithelial carcinoma cell line [32]. In the heart the role of NF-B is 
controversial as it may convey both pro- and anti-apoptotic signals [33]. 
Nevertheless, recent data are consistent with a detrimental role of NF-B in 
heart failure [34]. NF-B inhibition might be the other signaling event required 
for fragment N to protect cardiomyocytes as recently shown in pancreatic 
beta cells [16]. However, inhibition of the NF-B pathway did not alter cardiac 
cell apoptosis induced by either low or high concentrations of PN (Fig. S1). 
This would suggest that fragment N does not use its NF-B inhibitory 
capacity to protect cardiomyocytes against PN-induced death. It cannot 
however be excluded that it is the interplay between Akt activation and NF-
B inhibition generated by fragment N that induces a more potent survival 
response than when Akt and NF-B are regulated separately. The protective 
pathways regulated by fragment N need to be better characterized as they 
16 
represent potential targets for the development of cardiac protective 
therapies. 
The loss of adult cardiomyocytes by necrosis or apoptosis is a major factor in 
the initiation and progression of heart failure as it contributes to the decline in 
myocardium function [35]. This process is mediated at least in part by PN, 
which has emerged as a key mediator of cardiomyocyte injury in numerous 
cardiac pathologies, including myocardial ischemia reperfusion injury, 
myocarditis, cardiac allograft rejection and anthracycline-induced 
cardiomyopathy (see [28] for an extended review on this topic). In such 
conditions, multiple molecular mechanisms have been shown to contribute to 
peroxynitrite-mediated cytotoxicity, ultimately resulting in the demise of 
cardiac myocytes, both via the necrotic and apoptotic pathways [10]. 
Therefore, in light of our current in vitro findings, future in vivo studies should 
be designed to assess the importance of fragment N cleavage by PN as a 
contributing mechanism to cardiomyocyte death in the aforementioned 
pathological conditions. 
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Figures legends 
 
Fig. 1. Apoptosis and RasGAP cleavage kinetics following PN stimulation. 
One hundred fifty thousand H9C2 cells were seeded in 6-well plates cultured 
overnight. One day later, the cells were washed once with PBS, placed in 
phosphate-buffered saline and stimulated with 250 μM PN for 20 minutes. 
After PN stimulation, the cells were placed in complete culture medium for 
the indicated periods of time before being lysed. The levels of caspase-3 
activation (panel A) and the extent of RasGAP cleavage (panel B) were 
determined by Western blotting using an antibody recognizing both pro-
caspase-3 and the cleaved, active form of the protease, and an antibody 
recognizing RasGAP fragment N2 sequences, respectively. In both cases, 
actin levels were also evaluated by reprobing the blots with an actin-specific 
antibody. The graphs under the blots present the quantitation of the Western 
blot band intensities normalized to the highest values. (C) Alternatively, the 
cells were fixed with 2% PFA and apoptosis was determined by scoring cells 
with pyknotic or fragmented nucleus. In each panel, data correspond to the 
mean ± 95% CI of three independent experiments. 
 
Fig. 2. PN does not induce sequential cleavage of RasGAP in H9C2 cells. 
H9C2 cells were treated as in Figure 1 with the indicated PN concentrations 
for 20 minutes. After PN stimulation, the cells were placed in complete 
culture medium for an additional 4 hour-period before being lysed. Caspase-
3 activation (panel A), RasGAP cleavage (panel B), and apoptosis (panel C) 
were assessed as described in Figure 1. (D) Akt activation was investigated 
by Western blot analysis using a phospho-serine473 Akt-specific antibody. 
The blot was reprobed with an actin-specific antibody. Finally, the blot was 
stripped and probed with an antibody recognizing total Akt. Quantitation of 
the Western blot band intensities for caspase-3 and RasGAP was performed 
as in Figure 1. Phospho-Akt band intensities were normalized to the total Akt 
intensities and the resulting ratios were normalized to the highest values. In 
each panel, results correspond to the mean ± 95% CI of three independent 
experiments. 
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Fig. 3. Cisplatin induces a sequential cleavage of RasGAP in cardiac cells. 
H9C2 cells were seeded and cultured as in Figure 1. The cells were then 
incubated with the indicated concentrations of cisplatin for 24 hours. 
Caspase-3 activation (panel A), RasGAP cleavage (panel B), apoptosis 
(panel C), and Akt activation (panel D) were assessed as described in Figure 
2. 
Fig. 4. PN does not induce sequential cleavage of RasGAP in HeLa cells. 
HeLa cells were treated and analyzed as described for H9C2 cells in Fig. 2. 
 
Fig. 5. Fragment N-mediated protection against PN in H9C2 cells. H9C2 
cells (80,000) were infected with an empty lentivirus or with lentiviruses 
encoding the HA-tagged wild-type form (HA-N) or the caspase-resistant 
D157A form [HA-N(D157A)] of fragment N. (A) Three days after infection the 
efficiency of fragment N expression was determined by 
immunocytochemistry. About 85% of the cells were found to express 
fragment N. (B) The cells were stimulated for 20 minutes with the indicated 
concentrations of PN and incubated for a further 7 hour-period, then starved 
for one hour in serum-free medium to ensure low basal Akt-Ser473 
phosphorylation. Finally the cells were lysed and expression of HA-tagged 
fragment N, the phosphorylation of Akt at serine 473, and caspase-3 
cleavage were assessed by Western blotting using the indicated antibodies. 
(C) The expression levels of HA-N and HA-N(D157A) were normalized to 
actin and further normalized to the expression value of control cells (0 µM 
PN). (D) Alternatively, three days post-infection, the cells were treated as 
indicated in panel B. The cells were then were fixed and the percentage of 
apoptotic cells determined. (E) Overexpression of a constitutive active Akt 
form protects cardiomyocyte against apoptosis induced by intermediate PN 
doses. H9C2 cells (150,000) were co-transfected with a GFP-expressing 
plasmid with either an empty vector or a plasmid encoding the constitutively 
active myr-Akt construct. The expression levels of activated Akt were 
detected by Western blotting as indicated in Figure 2. Alternatively the 
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transfected were treated with the indicated concentrations of PN for four 
hours and apoptosis was then scored in GFP-positive cells. (F) Fragment N2 
has no effect on PN-induced apoptosis. H9C2 cells (150’000) were co-
transfected with a GFP expressing plasmid (GFP.dn3) in combination with 
S·tag- or S·tag-N2-expressing plasmids. S·tag-N2 expression levels were 
detected by immune-blotting using HRP-conjugated S-protein. Alternatively 
the transfected cells were treated with the indicated concentrations of PN for 
four hours and then apoptosis was scored in GFP-expressing cells. Results 
in panels C-F correspond to the mean ± 95% CI of three independent 
experiments performed in monoplicate (panels C-D) or in duplicate (panels 
E-F). Statistical significance was assessed by one-way ANOVAs. 
Fig. 6. A caspase-resistant fragment N protects primary cardiomyocytes from 
PN-induced apoptosis. Seventy-five thousands primary cardiomyocytes were 
seeded in 24-well plates and cultured for three days. (A) The cells were then 
infected wih an empty lentivirus or with lentiviruses encoding the HA-tagged 
wild-type form (HA-N) or the caspase-resistant D157A form [HA-N(D157A)] 
of fragment N. The purity of the cardiomyocyte preparation was monitored by 
immuno-fluorescence using an alpha actinin-specific antibody, and the 
efficiency of fragment N expression was determined by 
immunocytochemistry. (B) The cells were stimulated for 40 minutes with the 
indicated concentrations of PN and then treated and analyzed as indicated in 
Figure 5B. Alternatively, the infected cardiomyocytes were left untreated or 
stimulated for 40 minutes with 50, 100 or 250 µM PN. Eight hours later, 
apoptosis was determined by scoring the percentage of cells with pyknotic or 
fragmented nuclei (panel C) or by measuring the extent of DNA-coated 
histones released from nuclei (panel D). Results correspond to the mean ± 
95% CI of three independent experiments performed in triplicates. The 
indicated p values were derived from paired t-tests. Asterisks indicate 
statistically significant differences after Bonferonni corrections. 
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